# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Gainers Zomedica Corp. (NYSE: ZOM) shares surged 92.2% to close at $0.93 on Monday after surging 21% on Friday. The company,...
-SEC Filing
Gainers Zomedica Corp. (NYSE: ZOM) shares jumped 77.5% to $0.8591 after surging 21% on Friday. The company, last week, appoi...
Company obtains exclusive rights to develop and commercialize antibody therapeutics targeting insulin-like growth factor-1 rece...